Hepatic dysfunction after repeated isoflurane administration

Area of Science:

• Anesthesiology
• Hepatology
• Toxicology

Background:

• Halogenated volatile anesthetics like halothane are known to cause distinct hepatic injury syndromes.
• Isoflurane, another volatile anesthetic, has not been definitively linked to a specific hepatotoxicity syndrome.
• Previous suspected cases of isoflurane-induced liver injury remain debated.

Observation:

• A patient with no history of liver disease experienced recurrent hepatitis.
• These hepatitis episodes occurred following repeated administrations of isoflurane.
• No liver biopsy was performed in this case.

Findings:

• The temporal association between isoflurane exposure and hepatitis episodes was notable.
• The recurrent nature of the liver injury suggests a potential causal relationship.
• This case provides further evidence supporting isoflurane as a potential hepatotoxin.

Implications:

• Clinicians should consider isoflurane-induced hepatotoxicity in patients presenting with unexplained hepatitis after anesthesia.
• Further research and case reporting are needed to fully elucidate the risk of isoflurane-associated liver injury.
• This finding may influence anesthetic choices in patients with or at risk for liver disease.